Helicore Biopharma
Helicore Bio — Long-Acting Medicines to Transform Metabolic Health
South San Francisco, United States · $65.0M raised
- Headquarters
- South San Francisco, California
- Employees
- 1–10
- Business Model
- B2B
- Website
- helicore.com
- Total Funding
- $65.0M
- Last Round
- $65.0M Series AJan 2025
- Rounds
- 1
About
Clinical-stage biopharmaceutical company developing innovative therapeutics to address obesity and related metabolic diseases.
Summary
Helicore Biopharma is a Biotech company based in South San Francisco, United States. It has raised $65.0M in total across 1 round, most recently a $65.0M Series A round in Jan 2025. Investors include Jerel Davis, OrbiMed and Longitude Capital.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2025
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.